Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy

Progress in the use of traditional chemotherapy and radiation-based strategies for the treatment of pediatric malignancies has plateaued in the past decade, particularly for patients with relapsing or therapy refractory disease. As a result, cellular and humoral immunotherapy approaches have been in...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael A. Huang, Deepa K. Krishnadas, Kenneth G. Lucas
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/675269
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690131076743168
author Michael A. Huang
Deepa K. Krishnadas
Kenneth G. Lucas
author_facet Michael A. Huang
Deepa K. Krishnadas
Kenneth G. Lucas
author_sort Michael A. Huang
collection DOAJ
description Progress in the use of traditional chemotherapy and radiation-based strategies for the treatment of pediatric malignancies has plateaued in the past decade, particularly for patients with relapsing or therapy refractory disease. As a result, cellular and humoral immunotherapy approaches have been investigated for several childhood cancers. Several monoclonal antibodies are now FDA approved and commercially available, some of which are currently considered standard of practice. There are also several new cellular immunotherapy approaches under investigation, including chimeric antigen receptor (CAR) modified T cells, cancer vaccines and adjuvants, and natural killer (NK) cell therapies. In this review, we will discuss previous studies on pediatric cancer immunotherapy and new approaches that are currently being investigated in clinical trials.
format Article
id doaj-art-ec3b0465df3f45f797a477e891ce03a0
institution DOAJ
issn 2314-8861
2314-7156
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-ec3b0465df3f45f797a477e891ce03a02025-08-20T03:21:24ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/675269675269Cellular and Antibody Based Approaches for Pediatric Cancer ImmunotherapyMichael A. Huang0Deepa K. Krishnadas1Kenneth G. Lucas2Department of Pediatrics, Hematology/Oncology, University of Louisville, Louisville, KY 40202, USADepartment of Pediatrics, Hematology/Oncology, University of Louisville, Louisville, KY 40202, USADepartment of Pediatrics, Hematology/Oncology, University of Louisville, Louisville, KY 40202, USAProgress in the use of traditional chemotherapy and radiation-based strategies for the treatment of pediatric malignancies has plateaued in the past decade, particularly for patients with relapsing or therapy refractory disease. As a result, cellular and humoral immunotherapy approaches have been investigated for several childhood cancers. Several monoclonal antibodies are now FDA approved and commercially available, some of which are currently considered standard of practice. There are also several new cellular immunotherapy approaches under investigation, including chimeric antigen receptor (CAR) modified T cells, cancer vaccines and adjuvants, and natural killer (NK) cell therapies. In this review, we will discuss previous studies on pediatric cancer immunotherapy and new approaches that are currently being investigated in clinical trials.http://dx.doi.org/10.1155/2015/675269
spellingShingle Michael A. Huang
Deepa K. Krishnadas
Kenneth G. Lucas
Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
Journal of Immunology Research
title Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
title_full Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
title_fullStr Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
title_full_unstemmed Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
title_short Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy
title_sort cellular and antibody based approaches for pediatric cancer immunotherapy
url http://dx.doi.org/10.1155/2015/675269
work_keys_str_mv AT michaelahuang cellularandantibodybasedapproachesforpediatriccancerimmunotherapy
AT deepakkrishnadas cellularandantibodybasedapproachesforpediatriccancerimmunotherapy
AT kennethglucas cellularandantibodybasedapproachesforpediatriccancerimmunotherapy